Menadione sodium bisulfite
Menadione sodium bisulfite has been studied in 1 paper since 2024: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Oct 25, 2024: “Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function”.
See all 4 papers on menadione sodium bisulfite
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Agios Pharmaceuticals and others
- 3 of 3 findings with company ties
- Animals1
What did studies of menadione sodium bisulfite find?
3Studies of menadione sodium bisulfite measured 3 outcomes: lifespan, PIK3C3 and prostate cancer.
Lifespan
upin mice1
1 study
Lifespan
upin mice1
Menadione sodium bisulfite extends lifespan in a myotubular myopathy model driven by loss of MTM1.
“dietary MSB improved muscle histology and function and extended life span.”
Animalsin a myotubular myopathy model driven by loss of MTM1dietary MSB
Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function
Science (New York, N.Y.)
PIK3C3
downin mouse cells1
1 study
PIK3C3
downin mouse cells1
Menadione sodium bisulfite inhibits PIK3C3 in mouse cells (through oxidation of key cysteines).
“MSB antagonizes the essential class III phosphatidylinositol (PI) 3-kinase VPS34”
Cellsthrough oxidation of key cysteines
Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function
Science (New York, N.Y.)
Prostate cancer
downin mice1
1 study
Prostate cancer
downin mice1
Menadione sodium bisulfite inhibits prostate cancer in mice.
“menadione sodium bisulfite (MSB)] suppresses PC progression in mice”
Animalsin mice
Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function
Science (New York, N.Y.)